Anthony S. Fauci

Also affiliated with Georgetown University Medical Center

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Kinetics of Plasma HIV Rebound in the Era of Modern Antiretroviral Therapy”.

Kinetics of Plasma HIV Rebound in the Era of Modern Antiretroviral Therapy

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa270

N/A

1.6DataRank · unranked

37 citations

Erin Huiting, Katherine E. Clarridge, Catherine Seamon, Jana Blažková, J. Shawn Justement +8 more

A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques

Nature Medicine(2021)10.1038/s41591-021-01574-5

N/A

0.769DataRank · unranked

167 citations

Elisabeth Narayanan, Qingbo Liu, Yaroslav Tsybovsky, Kristin L. Boswell, Shilei Ding +31 more

Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses

Cell(2022)10.1016/j.cell.2022.09.032

N/A

0.637DataRank · unranked

69 citations

Lela Kardava, Omar El Merhebi, Sandeep Narpala, Leonid Serebryannyy, Bob C. Lin +17 more

Pre-vaccination and early B cell signatures predict antibody response to SARS-CoV-2 mRNA vaccine

medRxiv(2021)10.1101/2021.07.06.21259528

N/A

0.241DataRank · unranked

4 citations

Nicholas Rachmaninoff, William W. Lau, Clarisa M. Buckner, Krittin Trihemasava, Felipe Lopes de Assis +22 more

Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab305

N/A

0DataRank · unranked

41 citations

James M. Anderson, Annaliesa S. Anderson, David Baker, Jay Bradner, Kyle R. Brimacombe +37 more

Human Immunodeficiency Virus/AIDS in the Era of Coronavirus Disease 2019: A Juxtaposition of 2 Pandemics

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab114

N/A

0DataRank · unranked

40 citations

Andrea Lerner, Anthony S. Fauci, Robert W. Eisinger

COVID-19: The therapeutic landscape

Med(2021)10.1016/j.medj.2021.04.015

N/A

0DataRank · unranked

25 citations

Anthony S. Fauci, Catharine I. Paules

Blocking α 4 β 7 integrin delays viral rebound in SHIV SF162P3 -infected macaques treated with anti-HIV broadly neutralizing antibodies

Science Translational Medicine(2021)10.1126/scitranslmed.abf7201

N/A

0DataRank · unranked

17 citations

Mariasole Cigoli, Muhammad Arif, Marissa Fahlberg, Stephanie Maldonado, Giulia Calenda +21 more

Prolonged viral suppression with anti-HIV-1 antibody therapy

Nature(2022)10.1038/s41586-022-04597-1

N/A

0DataRank · unranked

209 citations

Lilian Nogueira, Elina Stoffel, Thiago Y. Oliveira, Gaëlle Breton, Katrina G. Millard +19 more

Combination anti-HIV antibodies provide sustained virological suppression

Nature(2022)10.1038/s41586-022-04797-9

N/A

0DataRank · unranked

178 citations

Jana Blažková, J. Shawn Justement, Victoria Shi, Brooke D. Kennedy, Kathleen Gittens +15 more

Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac296

N/A

0DataRank · unranked

65 citations

Theodore C. Pierson, L. Jean Patterson, Karin Bok, Amanda J DeRocco, Anne M. Deschamps +4 more

Early human B cell signatures of the primary antibody response to mRNA vaccination

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2204607119

N/A

0DataRank · unranked

39 citations

Nicholas Rachmaninoff, William W. Lau, Clarisa M. Buckner, Krittin Trihemasava, Jana Blažková +18 more

Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report

Annals of the New York Academy of Sciences(2022)10.1111/nyas.14898

N/A

0DataRank · unranked

12 citations

Anthony S. Fauci, William E. Dowling, Stephan Günther, Dennis A. Bente, Pragya D. Yadav +29 more

Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination

medRxiv(2022)10.1101/2022.08.30.22279344

N/A

0DataRank · unranked

1 citations

Lela Kardava, Omar El Merhebi, Sandeep Narpala, Leonid Serebryannyy, Bob C. Lin +17 more

Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses

Cell Host & Microbe(2023)10.1016/j.chom.2022.11.016

N/A

0DataRank · unranked

200 citations

Jeffery K. Taubenberger, Anthony S. Fauci, David M. Morens

Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report

npj Vaccines(2023)10.1038/s41541-023-00654-6

N/A

0DataRank · unranked

114 citations

Lucas E. Buyon, Rebecca Mandt, R. Farkas, Shobana Balasingam, Karin Bok +14 more

Pandemic Preparedness and Response: Lessons From COVID-19

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad095

N/A

0DataRank · unranked

63 citations

Gregory K. Folkers, Anthony S. Fauci

Refocusing Human Microbiota Research in Infectious and Immune-mediated Diseases: Advancing to the Next Stage

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa706

N/A

0DataRank · unranked

7 citations

Johanna Sophie Schneider, Thomas Calder, Anthony S. Fauci, Maria Y. Giovanni

SARS-CoV-2 Variants of Concern in the United States—Challenges and Opportunities

JAMA(2021)10.1001/jama.2021.2294

N/A

0DataRank · unranked

381 citations

Henry Walke, Anthony S. Fauci, Rochelle P. Walensky

Universal Coronavirus Vaccines — An Urgent Need

New England Journal of Medicine(2021)10.1056/nejmp2118468

N/A

0DataRank · unranked

141 citations

Jeffery K. Taubenberger, Anthony S. Fauci, David M. Morens